Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | Group President | November 11, 2022 | November 15, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date November 11, 2022 · Filed November 15, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 202,443 |
Ending reported balance
After 2022-11-11 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-11-11 · Exercise / conversion · Acquired 12,000 · Balance 211,883 Row 2 · 2022-11-11 · Tax withholding · Disposed 9,440 · Balance 202,443 |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $145.24 · Expires 2030-01-29 | Direct | 23,880 |
Reported balance
After 2022-11-11 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-11-11 · Exercise / conversion · Disposed 12,000 · Balance 23,880 F1: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. |
| Common StockSEC Table I · non-derivative | IndirectBy 2021 Family GRAT | 4,525 |
Reported balance
Holding disclosure · report date 2022-11-11 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,525 |
Filing footnotes · ownership attribution and instrument terms
F1: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2018 Filed Feb 2, 2018 19:39 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 33,744 | $102.24 | $3,449,986.56 |
DisclosureSEC source: 0001209191-18-007225 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,493 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:39 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 102,629 | $22.64 | $2,323,674.50 |
DisclosureSEC source: 0001209191-18-007225 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:39 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 36,600 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007225 · doc4.xml · derivative · entry 4 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,600 Underlying: Common Stock · 36,600 shares Expires 2028-01-31 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| February 25, 2017 Filed Mar 1, 2017 00:24 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 1,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015504 · doc4.xml · derivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,661 Underlying: Common Stock · 1,660 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On February 25, 2015, the reporting person was granted 3,321 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. Read SEC document |
| February 25, 2017 Filed Mar 1, 2017 00:24 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 1,107 | $87.07 | $96,386.49 |
DisclosureSEC source: 0001209191-17-015504 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,608 Read SEC document |
| February 25, 2017 Filed Mar 1, 2017 00:24 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 1,660 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-015504 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 22, 2017 Filed Feb 25, 2017 00:00 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 7,500 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-17-014525 · doc4.xml · derivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2024-02-05 F2 · balance_after: On February 5, 2014, the reporting person was granted 37,500 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 7,500 stock appreciation rights. Read SEC document |
| February 22, 2017 Filed Feb 25, 2017 00:00 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 11,000 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-17-014525 · doc4.xml · derivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2023-02-06 F1 · balance_after: On February 6, 2013, the reporting person was granted 55,000 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 11,000 stock appreciation rights. Read SEC document |
| February 03, 2017 Filed Feb 8, 2017 00:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 31,086 | $0.00 Strike: $22.64 | $0.00 |
DisclosureSEC source: 0001209191-17-008458 · doc4.xml · derivative · entry 5 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,266 Underlying: Common Stock · 31,086 shares Expires 2019-10-06 F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.exercise_date: Two thirds of the option was vested upon grant on October 6, 2009, and one third of the option vested on November 17, 2009. F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 03, 2017 Filed Feb 8, 2017 00:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 68,914 | $0.00 Strike: $17.65 | $0.00 |
DisclosureSEC source: 0001209191-17-008458 · doc4.xml · derivative · entry 4 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 68,914 shares Expires 2019-10-06 F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 03, 2017 Filed Feb 8, 2017 00:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 100,000 | $83.79 | $8,378,800.00 |
DisclosureSEC source: 0001209191-17-008458 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,055 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.50 to $84.00, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2017 Filed Feb 8, 2017 00:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 31,086 | $22.64 | $703,833.67 |
DisclosureSEC source: 0001209191-17-008458 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2017 Filed Feb 8, 2017 00:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 68,914 | $17.65 | $1,216,132.25 |
DisclosureSEC source: 0001209191-17-008458 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 4, 2017 00:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 15,536 | $0.00 Strike: $17.65 | $0.00 |
DisclosureSEC source: 0001209191-17-007876 · doc4.xml · derivative · entry 6 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,914 Underlying: Common Stock · 15,536 shares Expires 2019-10-06 F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 02, 2017 Filed Feb 4, 2017 00:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 84,464 | $0.00 Strike: $13.21 | $0.00 |
DisclosureSEC source: 0001209191-17-007876 · doc4.xml · derivative · entry 5 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,464 shares Expires 2019-10-06 F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| February 02, 2017 Filed Feb 4, 2017 00:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 100,000 | $82.38 | $8,238,430.00 |
DisclosureSEC source: 0001209191-17-007876 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,055 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.25 to $82.76, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2017 Filed Feb 4, 2017 00:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 15,536 | $17.65 | $274,165.35 |
DisclosureSEC source: 0001209191-17-007876 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 4, 2017 00:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 84,464 | $13.21 | $1,115,558.28 |
DisclosureSEC source: 0001209191-17-007876 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:16 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 27,510 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007876 · doc4.xml · derivative · entry 4 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,510 Underlying: Common Stock · 27,510 shares Expires 2027-02-01 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.